0000899243-17-024252.txt : 20171016 0000899243-17-024252.hdr.sgml : 20171016 20171016170750 ACCESSION NUMBER: 0000899243-17-024252 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171013 FILED AS OF DATE: 20171016 DATE AS OF CHANGE: 20171016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chern Carey CENTRAL INDEX KEY: 0001688374 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 171139316 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-13 1 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001688374 Chern Carey 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 General Counsel Common Stock 2017-10-13 4 M 0 30000 A 31982 D Common Stock 2017-10-13 4 F 0 11274 11.18 D 20708 D Common Stock 2017-10-13 4 D 0 20708 11.18 A 0 D Incentive Stock Option (right to buy) 10.35 2017-10-13 4 D 0 38644 0.83 D 2026-11-14 Common Stock 38644 0 D Non-Qualified Stock Option (right to buy) 10.35 2017-10-13 4 D 0 41356 0.83 D 2026-11-14 Common Stock 41356 0 D Restricted Stock Unit 2017-10-13 4 M 0 30000 D Common Stock 30000 0 D Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement. Includes 773 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on May 31, 2017; 746 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on August 31, 2017; and 463 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on October 6, 2017. Granted under Issuer's 2015 Equity Incentive Plan. Under its terms the option became exercisable in installments with 25% vesting on October 24, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger"). The option was canceled immediately prior to the Merger in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price. Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock. /s/ Carey Chern 2017-10-16